Home › Esperion Announces Positive Topline Results from a Phase 2 Clinical...
 

Keywords :   


Esperion Announces Positive Topline Results from a Phase 2 Clinical...

2013-01-08 02:44:31| Biotech - Topix.net

Esperion Therapeutics, the leading developer of small molecule therapies for the treatment of cardiometabolic disorders, today announced positive results of a recently completed Phase 2 clinical trial of ETC-1002 in patients with type 2 diabetes with LDL-C lowering of up to 43% compared to placebo.

Tags: results positive phase clinical

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
07.10Hurricane Milton Potential Storm Surge Flooding Map
07.10Hurricane Milton Probabilistic Storm Surge Graphics
07.10Hurricane Milton Graphics
07.10Hurricane Leslie Forecast Discussion Number 19
07.10Hurricane Milton Forecast Discussion Number 7
07.10Hurricane Milton Wind Speed Probabilities Number 7
07.10Hurricane Leslie Graphics
07.10Hurricane Milton Forecast Advisory Number 7
More »